...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

Free
Message: Re: A couple of things
6
May 02, 2022 01:38PM
2
May 02, 2022 01:57PM
3
May 02, 2022 02:25PM
4
May 02, 2022 05:00PM
5
May 02, 2022 06:16PM
6
May 02, 2022 06:47PM
9
May 03, 2022 01:38AM
1
May 03, 2022 09:33AM
6
May 03, 2022 11:09AM
5
May 03, 2022 12:12PM
4
May 03, 2022 12:26PM
1
May 03, 2022 12:30PM
9
May 03, 2022 12:34PM
2
May 03, 2022 01:28PM

My investment account is proof of the loses incurred - can't deny that. Waiting for data lock and trial results. Any day now in the words of Mr McAffery. My current expectation is end of May. My presumption is that a trial is being conducted in Brazil until I hear otherwise. They couldn't get it done on their home turf in Calgary and Canada - why? Management communications are pathetic to say the least and have adversely affected the market value of RVX. This trial is a Phase 2b with only 100 patients -  let's get the results please!

2
May 03, 2022 01:52PM
3
May 05, 2022 01:00AM
1
May 05, 2022 10:42AM
Share
New Message
Please login to post a reply